Skip to main content
52°
Clear
Site search
Search
Menu
Search
Subscribe
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
News
Local News
State News
Sports
Local Sports
Pro Sports
Lifestyle
Local Entertainment
Multimedia
Community Choice
Features
Special Sections
Local Events
Weather
Classifieds
Place Ad
Legal Notices
Place Call Legal
Search Call Legals
Place Times Legal
Search Times Legals
Public Notices
Obituaries
E-Edition
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about INCY
Recent news which mentions INCY
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
The Daily Biotech Pulse: Restricted Authorization For Pfizer's COVID-19 Booster Dose, AbCellera Strikes Antibody Licensing Deal, Solid Biosciences Issues DMD Data
September 23, 2021
Tickers
ABCL
ABSI
AFIB
ALZN
Tags
BEAM
vaccine
ABSI
From
Benzinga
10 Biggest Price Target Changes For Thursday
September 23, 2021
Tickers
FDX
INCY
KBH
LEN
Tags
LEN
Consumer Discretionary
Benzinga
From
Benzinga
Back To Back FDA Approval For Incyte - This Time For Jakafi In GVHD
September 22, 2021
Tickers
INCY
Tags
Movers
Briefs
General
From
Benzinga
Facebook, Incyte Fall Despite the Nasdaq's Strong Wednesday Start
September 22, 2021
Tickers
FB
INCY
Tags
Market News
FB
INCY
From
Motley Fool
The Daily Biotech Pulse: Pfizer-BioNTech US Vaccine Contract, Summit Slumps On Adverse Regulatory Feedback, Cerevel CFO Departs
September 22, 2021
Tickers
ABEO
ABSI
AFIB
AMAM
Tags
MIRO
KROS
BLUE
From
Benzinga
Incyte's Topical JAK Inhibitor Scores FDA Approval For Atopic Dermatitis
September 22, 2021
Tickers
INCY
Tags
atopic dermatitis
General
Briefs
From
Benzinga
The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data
September 21, 2021
Tickers
ABSI
ADTX
AERI
AFIB
Tags
FDA
Biotech
HCWB
From
Benzinga
Incyte's Pemazyre Wins Conditional Approval For Bile Duct Cancer In Canada
September 20, 2021
Tickers
INCY
Tags
General
Benzinga
FDA
From
Benzinga
Is AbbVie a Bad News Buy?
September 19, 2021
Tickers
ABBV
INCY
LLY
PFE
Tags
LLY
Market News
PFE
From
Motley Fool
The Week Ahead In Biotech (Sept. 19-25): Incyte, Verrica FDA Decisions And Conference Presentations In The Spotlight
September 19, 2021
Tickers
AGTC
APRE
BMY
BNTX
Tags
ONTX
TAK
SRPT
From
Benzinga
Price Over Earnings Overview: Incyte
September 14, 2021
Tickers
INCY
Tags
Intraday Update
Benzinga
Markets
From
Benzinga
FDA Hits JAK inhibitors With Heart Safety, Cancer Warnings: All You Need To Know
September 02, 2021
Tickers
ABBV
BMY
INCY
LLY
Tags
Benzinga
FDA
Biotech
From
Benzinga
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
August 31, 2021
Tickers
ABBV
ASND
BGNE
BIIB
Tags
SNY
Top Stories
Market News
From
Benzinga
If you’ve got the stock market jitters, here are 20 companies in two defensive sectors
August 30, 2021
Tickers
ABC
AES
ANTM
BAX
Tags
CVS
ANTM
VRTX
From
MarketWatch
The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration
August 27, 2021
Tickers
AGEN
ALKS
ALZN
BLFS
Tags
PDSB
NUVL
Benzinga
From
Benzinga
Incyte - MorphoSys's Diffuse Large B-Cell Lymphoma Drug Wins European Approval
August 27, 2021
Tickers
INCY
MOR
Tags
Briefs
Biotech
FDA
From
Benzinga
These 20 ‘left behind’ stocks among the S&P 500 are expected to rise up to 59% over 12 months
August 26, 2021
Tickers
AAPL
AMZN
ATVI
BAX
Tags
EA
ZBH
SPX
From
MarketWatch
BriaCell, ImaginAb Join Forces To Assess Imaging Tech In Breast Cancer Trial
August 19, 2021
Tickers
BCTX
INCY
Tags
Market News
News
INCY
From
Benzinga
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
August 17, 2021
Tickers
ABSI
ABVC
ACAD
ACHV
Tags
CLBS
OTIC
GLTO
From
Benzinga
Incyte Out Licenses Lymphoma Drug To InnoCare In Greater China
August 17, 2021
Tickers
INCY
MOR
XNCR
Tags
XNCR
Briefs
General
From
Benzinga
BriaCell Therapeutics Attacks Cancer with Novel Off-the-Shelf Immunotherapies
August 16, 2021
Tickers
INCY
Tags
General
Benzinga
Partner Content
From
Benzinga
The Daily Biotech Pulse: Moderna's Vaccine Produces Durable Response Against Variants, FDA Approves Jazz's Sleep Disorder Drug, Dermata IPO
August 13, 2021
Tickers
ABVC
ACAD
ACHL
ADGI
Tags
CLRB
KPTI
DRNA
From
Benzinga
The Daily Biotech Pulse: Xeris Gets OK For Initiating Hyperthyroidism Study, Merck-Eisai Snag FDA Approval For Drug Combo, Decision Day For Jazz Pharma
August 12, 2021
Tickers
ABCL
ACET
ACHV
ADGI
Tags
IKNA
CRMD
ELYM
From
Benzinga
The Daily Biotech Pulse: FDA Rejects FibroGen's Anemia Drug, Crinetics Gains On Positive Readout, BioCryst Withdraws Public Offering
August 11, 2021
Tickers
ACAD
ACHV
ADMA
AKRO
Tags
PFE
RPRX
XENT
From
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
August 10, 2021
Tickers
ACAD
AKRO
APEI
ARNA
Tags
AXU
HMPT
EQX
From
Benzinga
The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts
August 10, 2021
Tickers
ACET
ADGI
AKRO
AKYA
Tags
IPOs
NVCN
DVAX
From
Benzinga
Is the PD-(L)1 Party Over After Incyte's FDA Rejection?
August 07, 2021
Tickers
BMY
INCY
L
MRK
Tags
INCY
Market News
BMY
From
Motley Fool
Incyte Corporation (INCY) Q2 2021 Earnings Call Transcript
August 03, 2021
Tickers
INCY
Tags
INCY
Market News
From
Motley Fool
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
August 02, 2021
Tickers
ALBO
AXSM
CARA
CCXI
Tags
Market News
Health Care
SNY
From
Benzinga
A Preview Of Incyte's Earnings
August 02, 2021
Tickers
INCY
Tags
INCY
Benzinga
Earnings
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.